Centurium considers stake sale in US$6 billion Taibang Biologic: sources
Chinese private equity firm Centurium Capital is considering selling its stake in Taibang Biologic Group, people familiar with the matter ...
Chinese private equity firm Centurium Capital is considering selling its stake in Taibang Biologic Group, people familiar with the matter ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.